HCW Biologics Announces Appointment of Two New Members to Board of Directors

NEXT STORY
Context Therapeutics® and Wisconsin Oncology Network Announce First Patient Dosed in Phase 2 Trial of ONA-XR in Metastatic Breast Cancer
PREV STORY
Sharps Compliance Reports Fiscal 2022 First Quarter Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

PMV Pharma Announces Closing of $243.5 Million Initial Public Offering and Exercise in Full of Underwriters’ Option to Purchase Additional Shares

author_avatar
NASDAQ Market News

Enterin and Their Collaborators at NIH Announce That Alpha-Synuclein, the Culprit in Parkinson’s Disease, is Core and Central to Normal Immune Function

author_avatar
NASDAQ Market News

RedHill Biopharma Announces U.S. Co-Promotion Agreement with Napo Pharmaceuticals for HIV/AIDS Anti-Diarrheal Drug Mytesi®

RedHill has been granted the exclusive right to co-promote Mytesi® (crofelemer 125 mg delayed-release ...

author_avatar
NASDAQ Market News